Cadernos de Saude Publica·Feb 7Dynapenia and sarcopenia: association with the diagnosis, duration and complication of type 2 diabetes mellitus in ELSA-BrasilCross-sectional study of 12,132 peopleDynapeniaPaper
Diabetes, Obesity & Metabolism·Jan 4Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan-O-AP and LixiLan-L-CN trialsRandomized trial in peopleType 2 diabetesPaper
Pharmacological Research·Dec 5Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysisMeta-analysis of randomized trialsTirzepatidePaper
Diabetes Therapy·Sep 28Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United StatesTrial in peopleTirzepatidePaper
American Heart Journal·Sep 25Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristicsRandomized trial in 13,299 peopleTirzepatidePaper
Journal of Diabetes and Its Complications·Sep 17Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong Diabetes RegisterCohort study of 986 peopleMild cognitive impairmentPaper
Diabetes Therapy·Sep 15Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 DiabetesReviewType 2 diabetesPaper
Journal of Alzheimer's Disease·Jul 24Reliability and Validity of Self-Reported Vascular Risk Factors: Hypertension, Diabetes, and Heart Disease, in a Multi-Ethnic Community Based Study of Aging and DementiaCross-sectional study of 1,870 peopleHeart diseasePaper
Current Medical Research and Opinion·Jul 10Semaglutide versus tirzepatide for people with type 2 diabetes: cost of glycemic control in Austria, the Netherlands, Lithuania, and the United Arab EmiratesTrial in peopleTirzepatidePaper
medRxiv·May 3Reliability and Validity of self-reported Vascular Risk Factors in a Multi-Ethnic Community Based Study of Aging and DementiaPreprint: cross-sectional study of 1,870 peopleBiomarkersPaper
JAMA Neurology·Apr 18Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 DiabetesCohort study of 253,211 peopleDementiaPaper
PLOS One·Dec 28Association of dietary magnesium intake and glycohemoglobin with mortality risk in diabetic patientsCohort study of 2,045 peoplePopulationsPaper
Frontiers in Endocrinology·Sep 8Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysisMeta-analysis of randomized trialsType 2 diabetesPaper
The Lancet Diabetes & Endocrinology·Jul 30Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trialRandomized trial in 443 peopleTirzepatidePaper
Journal of the American College of Cardiology·Jun 10Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) StudyCohort study of 4,774 peopleHeart failurePaper
The Lancet Diabetes & Endocrinology·Apr 22Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trialRandomized trial in 296 peopleTirzepatidePaper
Minerva Endocrinology·Oct 21Evaluation of diabetes self-management education in geriatrics with type 2 diabetes in TurkeyCohort study of 320 peopleType 2 diabetesPaper
Lancet·Jun 27Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trialRandomized trial in 478 peopleGLP-1 receptor agonistsPaper
Metabolism·May 25Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonistsReviewSGLT2 inhibitorsPaper
Research Square·May 58-year post operative survival after penile prothesis implantation: Less than expected perioperative riskPreprint: cohort study of 109 peoplePopulationsPaper
Scientific Reports·Apr 17The effects of type 2 diabetes mellitus on the corneal endothelium and central corneal thicknessStudy in peopleMechanismsPaper
BMC Geriatrics·Oct 25Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: The Mexican Health and Aging StudyStudy in peoplePopulationsPaper
Diabetes Therapy·Aug 28Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal InsufficiencyRandomized trial in 410 peopleType 2 diabetesPaper
BMC Endocrine Disorders·Aug 28Risk of mini-mental state examination (MMSE) decline in the elderly with type 2 diabetes: a Chinese community-based cohort studyStudy in peoplePopulationsPaper
Alzheimer's & Dementia·Aug 18Glucose control and cognitive and physical function in adults 80+ years of age with diabetesStudy in peoplePopulationsPaper
Diabetes, Obesity & Metabolism·Aug 4Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort studyStudy in peoplePopulationsPaper
Diabetes Therapy·May 29Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and RaceCohort study of 11,001 peopleType 2 diabetesPaper
Diabetes Therapy·Dec 11Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational StudyCohort study of 3,056 peopleLiraglutidePaper
Journal of Endocrinological Investigation·Jul 31One-year caloric restriction and 12-week exercise training intervention in obese adults with type 2 diabetes: emphasis on metabolic control and resting metabolic rateNon-randomized trial in 23 peopleDietary restrictionPaper
Diabetes Care·Jun 22The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC StudyStudy in peoplePopulationsPaper